VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 44 of Oncotarget features Figure 6A, "Autophagy inhibition enables dasatinib to reduce tumour volume in A549 mice xenografts," by Rupniewska, et al.
|
|
Table of Contents
Editorial: Autophagy and Cell Death
|
| XIAP at the crossroads of cell death and inflammation |
|
https://doi.org/10.18632/oncotarget.25363
|
| 27319-27320 |
Research Papers: Gerotarget (Focus on Aging)
|
| Genetic polymorphisms in ataxin3 and liver cirrhosis risk related to aflatoxin B1 |
|
https://doi.org/10.18632/oncotarget.24535
|
| 27321-27332 |
Research Papers: Pathology
|
| A pilot study of circulating microRNAs as potential biomarkers of Fabry disease |
|
https://doi.org/10.18632/oncotarget.25542
|
| 27333-27345 |
Research Papers
|
| Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors |
|
https://doi.org/10.18632/oncotarget.25213
|
| 27346-27362 |
|
| Identification characterization and application of a new peptide against anterior gradient homolog 2 AGR2 |
|
https://doi.org/10.18632/oncotarget.25221
|
| 27363-27379 |
|
| Neoadjuvant chemotherapy in breast cancer: a dosedense schedule in real life and putative role of PIK3CA mutations |
|
https://doi.org/10.18632/oncotarget.25270
|
| 27380-27396 |
|
| Cytogenetic damage analysis in mice chronically exposed to lowdose internal tritium betaparticle radiation |
|
https://doi.org/10.18632/oncotarget.25282
|
| 27397-27411 |
|
| The landscape of somatic mutation in sporadic Chinese colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25287
|
| 27412-27422 |
|
| Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma |
|
https://doi.org/10.18632/oncotarget.25384
|
| 27423-27434 |
|
| Synuclein gamma expression enhances radiation resistance of breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25415
|
| 27435-27447 |
|
| Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triplenegative breast cancer cells Results from the proofofconcept VICTOR0 study |
|
https://doi.org/10.18632/oncotarget.25422
|
| 27448-27459 |
|
| PDL1 is expressed on human platelets and is affected by immune checkpoint therapy |
|
https://doi.org/10.18632/oncotarget.25446
|
| 27460-27470 |
|
| Target amplicon exomesequencing identifies promising diagnosis and prognostic markers involved in RTKRAS and PI3KAKT signaling as central oncopathways in primary central nervous system lymphoma |
|
https://doi.org/10.18632/oncotarget.25463
|
| 27471-27486 |
|
| Anticancer binary system activated by bacteriophage HK022 integrase |
|
https://doi.org/10.18632/oncotarget.25512
|
| 27487-27501 |
|
| Sensitivity of pretargeted immunoPET using 68Gapeptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PETCT |
|
https://doi.org/10.18632/oncotarget.25514
|
| 27502-27513 |
|
| Protein expression patterns in cancerassociated fibroblasts and cells undergoing the epithelialmesenchymal transition in ovarian cancers |
|
https://doi.org/10.18632/oncotarget.25518
|
| 27514-27524 |
|
| Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population |
|
https://doi.org/10.18632/oncotarget.25537
|
| 27525-27534 |
|
| High miR100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids |
|
https://doi.org/10.18632/oncotarget.25541
|
| 27535-27546 |
|
| MutT homolog 1 counteracts the effect of antineoplastic treatments in adult and pediatric glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.25547
|
| 27547-27563 |
|
| Fertilitysparing surgery of malignant transformation arising from mature cystic teratoma of the ovary |
|
https://doi.org/10.18632/oncotarget.25548
|
| 27564-27573 |
|
| CD300A promotes tumor progression by PECAM1 ADCY7 and AKT pathway in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.24164
|
| 27574-27584 |
Corrections
|
| Correction: 6Shogaol attenuates LPSinduced inflammation in BV2 microglia cells by activating PPARγ |
|
https://doi.org/10.18632/oncotarget.25638
|
| 27585-27585 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
